Doheny Image Reading Center, Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Adv Exp Med Biol. 2021;1256:33-66. doi: 10.1007/978-3-030-66014-7_2.
Age-related macular degeneration (AMD) is a progressive neuro-retinal disease and the leading cause of central vision loss among elderly individuals in the developed countries. Modern ocular imaging technologies constitute an essential component of the evaluation of these patients and have contributed extensively to our understanding of the disease. A challenge with any review of ocular imaging technologies is the rapid pace of progress and evolution of these instruments. Nonetheless, for proper and optimal use of these technologies, it is essential for the user to understand the technical principles underlying the imaging modality and their role in assessing the disease in various settings. Indeed, AMD, like many other retinal diseases, benefits from a multimodal imaging approach to optimally characterize the disease. In this chapter, we will review the various imaging technologies currently used in the assessment and management of AMD.
年龄相关性黄斑变性（AMD）是一种进行性的神经视网膜疾病，也是发达国家中老年人视力丧失的主要原因。现代眼部成像技术是评估这些患者的重要组成部分，广泛促进了我们对该疾病的理解。任何眼部成像技术的评估都面临一个挑战，那就是这些仪器的快速发展和演进。尽管如此，为了正确和优化地使用这些技术，使用者理解成像方式背后的技术原理及其在各种情况下评估疾病的作用至关重要。实际上，AMD 与许多其他视网膜疾病一样，得益于多模态成像方法，从而可以最佳地对疾病进行特征描述。在本章中，我们将回顾目前用于评估和管理 AMD 的各种成像技术。
